- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 786365, 8 pages
Salvianolic Acid B Reducing Portal Hypertension Depends on Macrophages in Isolated Portal Perfused Rat Livers with Chronic Hepatitis
1Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China
2School of Basic Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
Received 9 July 2012; Accepted 29 August 2012
Academic Editor: Youn Chul Kim
Copyright © 2012 Xin Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. Bosch, A. Berzigotti, J. C. Garcia-Pagan, and J. G. Abraldes, “The management of portal hypertension: rational basis, available treatments and future options,” Journal of Hepatology, vol. 48, no. 1, supplement, pp. S68–S92, 2008.
- Y. S. Seo and V. H. Shah, “Pathophysiology of portal hypertension and its clinical links,” Journal of Clinical and Experimental Hepatology, vol. 1, no. 2, pp. 87–93, 2011.
- T. O. Cheng, “Cardiovascular effects of Danshen,” International Journal of Cardiology, vol. 121, no. 1, pp. 9–22, 2007.
- P. Liu, Y. Y. Hu, C. Liu et al., “Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B,” World Journal of Gastroenterology, vol. 8, no. 4, pp. 679–685, 2002.
- J. Zhang, W. W. Zhang, and L. M. Xu, “Effect and mechanism of salvianolic-acid B on inhibiting endothelin-1-induced contraction of human hepatic stellate cells,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 29, no. 1, pp. 60–64, 2009.
- H. Zhou, S. X. Wang, T. Zhang, et al., “Effects of salvianolic acid B and diammonium glycyrrhizinate on portal pressure in rats,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 30, no. 10, pp. 1084–1086, 2010.
- A. Rodríguez-Vilarrupla, M. Fernández, J. Bosch, and J. C. García-Pagán, “Current concepts on the pathophysiology of portal hypertension,” Annals of Hepatology, vol. 6, no. 1, pp. 28–36, 2007.
- L. Van Landeghem, W. Laleman, I. Vander Elst et al., “Carbon monoxide produced by intrasinusoidally located haem-oxygenase-1 regulates the vascular tone in cirrhotic rat liver,” Liver International, vol. 29, no. 5, pp. 650–660, 2009.
- N. G. Theodorakis, Y. N. Wang, J. M. Wu, M. A. Maluccio, J. V. Sitzmann, and N. J. Skill, “Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model,” American Journal of Physiology, vol. 297, no. 4, pp. G792–G799, 2009.
- M. Kajita, T. Murata, K. Horiguchi, M. Iizuka, M. Hori, and H. Ozaki, “iNOS expression in vascular resident macrophages contributes to circulatory dysfunction of splanchnic vascular smooth muscle contractions in portal hypertensive rats,” American Journal of Physiology, vol. 300, no. 3, pp. H1021–H1031, 2011.
- B. Laviña, J. Gracia-Sancho, A. Rodríguez-Vilarrupla et al., “Superoxide dismutase gene transfer reduces portal pressure in CCI 4 cirrhotic rats with portal hypertension,” Gut, vol. 58, no. 1, pp. 118–125, 2009.
- J. Gracia-Sancho, B. Laviña, A. Rodríguez-Vilarrupla et al., “Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis,” Gastroenterology, vol. 133, no. 3, pp. 959–966, 2007.
- N. G. Abraham and A. Kappas, “Pharmacological and clinical aspects of heme oxygenase,” Pharmacological Reviews, vol. 60, pp. 79–127, 2008.
- E. O. Farombi and Y. J. Surh, “Heme oxygenase-1 as a potential therapeutic target for hepatoprotection,” Journal of Biochemistry and Molecular Biology, vol. 39, no. 5, pp. 479–491, 2006.
- R. Kinobe, Y. Ji, and K. Nakatsu, “Peroxynitrite-mediated inactivation of heme oxygenases,” BMC Pharmacology, vol. 4, article 26, 2004.
- P. J. Murray and T. A. Wynn, “Obstacles and opportunities for understanding macrophage polarization,” Journal of Leukocyte Biology, vol. 89, no. 4, pp. 557–563, 2011.
- S. E. Lee, S. I. Jeong, H. Yang, et al., “Extract of Salvia miltiorrhiza (Danshen) induces Nrf2-mediated heme oxygenase-1 expression as a cytoprotective action in RAW 264.7 macrophages,” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 541–548, 2012.
- C. L. Liu, L. X. Xie, M. Li, S. S. K. Durairajan, S. Goto, and J. D. Huang, “Salvianolic acid B inhibits hydrogen peroxide-induced endothelial cell apoptosis through regulating PI3K/Akt signaling,” PLoS ONE, vol. 2, no. 12, Article ID e1321, 2007.
- S. Sethasine, D. Jain, R. J. Groszmann, et al., “Quantitative histological-hemodynamic correlations in cirrhosis,” Hepatology, vol. 55, no. 4, pp. 1146–1153, 2012.
- X. Y. Xu, T. Zhang, H. Zhou et al., “Portal pressure determined by perfusion velocity in isolated chronically injured rat liver in vitro,” World Chinese Journal of Digestology, vol. 18, no. 26, pp. 2745–2749, 2010.
- T. Zhang, X. Y. Xu, H. Zhou, et al., “A pharmacodynamic model for portal hypertension in rat,” World Journal of Gastroenterology, vol. 18, no. 5, pp. 472–478, 2012.
- X. Zhao, X. Y. Xu, T. Zhang, et al., “Diammonium glycyrrhizinate reduces portal hypertension in isolated portal perfused rat livers,” World Journal of Gastroenterology. In press.
- B. Vollmar and M. D. Menger, “The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair,” Physiological Reviews, vol. 89, no. 4, pp. 1269–1339, 2009.
- H. Gronbaek, T. D. Sandahl, C. Mortensen, et al., “Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis,” Alimentary Pharmacology & Therapeutics, vol. 36, no. 2, pp. 173–180, 2012.
- L. Ren, X. Zang, X. Deng, et al., “Wave characteristics of portal pressure and their affected factors,” Journal of Beijing University of Traditional Chinese Medicine, vol. 29, no. 12, pp. 840–843, 2006.
- C. Van Steenkiste, B. Trachet, C. Casteleyn et al., “Vascular corrosion casting: analyzing wall shear stress in the portal vein and vascular abnormalities in portal hypertensive and cirrhotic rodents,” Laboratory Investigation, vol. 90, no. 11, pp. 1558–1572, 2010.
- Y. Zhou, J. Gu, and L. M. Xu, “Effect and mechanism of salvianolic acid B in attenuating elevated portal pressure in a rat model of portal hypertension induced by endothelin-1,” Journal of Chinese Integrative Medicine, vol. 5, no. 1, pp. 61–64, 2007.
- T. Tian and L. M. Xu, “Effects of Salviae miltiorrhizae and salvianolic acid B on microcirculation of liver in mice with portal hypertension,” Journal of Chinese Integrative Medicine, vol. 7, no. 2, pp. 151–156, 2009.
- M. Hennenberg, J. Trebicka, T. Sauerbruch, and J. Heller, “Mechanisms of extrahepatic vasodilation in portal hypertension,” Gut, vol. 57, no. 9, pp. 1300–1314, 2008.
- H. L. Wu, Y. H. Li, Y. H. Lin et al., “Salvianolic acid B protects human endothelial cells from oxidative stress damage: a possible protective role of glucose-regulated protein 78 induction,” Cardiovascular Research, vol. 81, no. 1, pp. 148–158, 2009.
- J. H. C. Ho and C. Y. Hong, “Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection,” Journal of Biomedical Science, vol. 18, no. 1, article 30, 2011.
- S. C. Chen, Y. L. Lin, and B. Huang, “Salvianolic acid B suppresses IFN-gamma-induced JAK/STAT1 activation in endothelial cells,” Thrombosis Research, vol. 128, no. 6, pp. 560–564, 2011.
- F. F. Y. Lam, J. H. K. Yeung, Y. W. Kwan, K. M. Chan, and P. M. Y. Or, “Salvianolic acid B, an aqueous component of danshen (Salvia miltiorrhiza), relaxes rat coronary artery by inhibition of calcium channels,” European Journal of Pharmacology, vol. 553, no. 1–3, pp. 240–245, 2006.
- L. Hood, L. Rowen, D. J. Galas, and J. D. Aitchison, “Systems biology at the Institute for Systems Biology,” Briefings in Functional Genomics and Proteomics, vol. 7, no. 4, pp. 239–248, 2008.